Economic Burden of Surgical Site Infections Within the Episode of Care Following Joint Replacement

Overview

Journal J Orthop Surg Res

Publisher Biomed Central

Specialty Orthopedics

Date 2019 Jun 29

PMID 31248432

Citations 20

Authors

Ayoade Adeyemi

Paul Trueman

Affiliations

Soon will be listed here.

Abstract

Background: Recent policy initiatives, including Bundled Payments for Care Improvement (BPCI) Initiative by the Centers for Medicare and Medicaid Health Services (CMS), encourage healthcare providers to manage the total episode of care, rather than just the surgical episode. Surgical site infections (SSI) following total joint replacement result in preventable morbidity and suffering for patients and excess healthcare utilization for healthcare providers. This study sought to estimate the additional resources associated with SSIs within the 90-day episode of care following hip and knee joint replacement.

Methods: Using the 2013 Nationwide Readmissions Database (NRD), healthcare resource utilization was compared between propensity score matched patient groups with and without SSI-related readmissions within the 90-day episode of care following total joint replacement.

Results: Surgical site infections were associated with significantly longer hospital length of stay and increased costs following hip and knee joint replacement procedures. Generalized estimating equation regression results confirmed that additional costs associated with SSIs following both cohorts were significant, with additional hospital length of stay and costs following total hip and knee replacement procedures ranging from 4.9 to 5.2 days and $12,689 to $12,890, respectively.

Conclusion: Surgical site infections following total joint replacement account for significant additional healthcare resource use within the 90-day episode of care.

Citing Articles

Effectiveness of intra-articular vancomycin in preventing prosthetic joint infections in hip and knee arthroplasty: A systematic review and meta-analysis of RCT's.

Furtado da Cruz V, Machinski E, Richard da Silva Oliveira Filho A, Conde R, Varone B, Gobbi R J Orthop. 2025; 66:25-33.

PMID: 39872993 PMC: 11763160. DOI: 10.1016/j.jor.2024.12.025.

Prevalence of Surgical Site Infection After Hip Arthroplasty; a Systematic Review and Meta-Analysis.

Salehi R, Alizadeh-Otaghvar H, Farhadi B, Najafi M, Torabi H, Hojjati H Arch Acad Emerg Med. 2024; 12(1):e54.

PMID: 39290768 PMC: 11407543. DOI: 10.22037/aaem.v12i1.2308.

Etiology, Outcomes, and Complications of Total Hip Arthroplasty in Younger Patients: A Nationwide Big Data Analysis.

Maman D, Fournier L, Steinfeld Y, Berkovich Y J Clin Med. 2024; 13(15).

PMID: 39124801 PMC: 11313375. DOI: 10.3390/jcm13154535.

Prophylactic use of vancomycin powder on postoperative infection after total joint arthroplasty.

Gao J, Shu L, Jiang K, Muheremu A BMC Musculoskelet Disord. 2024; 25(1):68.

PMID: 38229109 PMC: 10790438. DOI: 10.1186/s12891-023-07024-2.

Effects of tourniquet on surgical site wound infection and pain after total knee arthroplasty: A meta-analysis.

Lin Z, Chen T, Chen G, Pan W, Xu W Int Wound J. 2023; .

PMID: 37779328 PMC: 10824622. DOI: 10.1111/iwj.14414.

References

Kurtz S, Lau E, Halpern M, Ong K . Trend shows growing orthopedic surgery case load. Will surgeons be able to keep up?. Mater Manag Health Care. 2006; 15(7):61-2. View

Kurtz S, Ong K, Lau E, Mowat F, Halpern M . Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007; 89(4):780-5. DOI: 10.2106/JBJS.F.00222. View

Kurtz S, Lau E, Schmier J, Ong K, Zhao K, Parvizi J . Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty. 2008; 23(7):984-91. DOI: 10.1016/j.arth.2007.10.017. View

Owens C, Stoessel K . Surgical site infections: epidemiology, microbiology and prevention. J Hosp Infect. 2008; 70 Suppl 2:3-10. DOI: 10.1016/S0195-6701(08)60017-1. View

Kurtz S, Lau E, Ong K, Zhao K, Kelly M, Bozic K . Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030. Clin Orthop Relat Res. 2009; 467(10):2606-12. PMC: 2745453. DOI: 10.1007/s11999-009-0834-6. View

de Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn B . Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control. 2009; 37(5):387-397. DOI: 10.1016/j.ajic.2008.12.010. View

Healy W, Rana A, Iorio R . Hospital economics of primary total knee arthroplasty at a teaching hospital. Clin Orthop Relat Res. 2010; 469(1):87-94. PMC: 3008872. DOI: 10.1007/s11999-010-1486-2. View

Peel T, Dowsey M, Daffy J, Stanley P, Choong P, Buising K . Risk factors for prosthetic hip and knee infections according to arthroplasty site. J Hosp Infect. 2011; 79(2):129-33. DOI: 10.1016/j.jhin.2011.06.001. View

Kurtz S, Lau E, Watson H, Schmier J, Parvizi J . Economic burden of periprosthetic joint infection in the United States. J Arthroplasty. 2012; 27(8 Suppl):61-5.e1. DOI: 10.1016/j.arth.2012.02.022. View

10.

Poultsides L, Ma Y, Gonzalez Della Valle A, Chiu Y, Sculco T, Memtsoudis S . In-hospital surgical site infections after primary hip and knee arthroplasty--incidence and risk factors. J Arthroplasty. 2012; 28(3):385-9. DOI: 10.1016/j.arth.2012.06.027. View

11.

Bozic K, Ong K, Lau E, Berry D, Vail T, Kurtz S . Estimating risk in Medicare patients with THA: an electronic risk calculator for periprosthetic joint infection and mortality. Clin Orthop Relat Res. 2012; 471(2):574-83. PMC: 3549162. DOI: 10.1007/s11999-012-2605-z. View

12.

Berstock J, Beswick A, Lenguerrand E, Whitehouse M, Blom A . Mortality after total hip replacement surgery: A systematic review. Bone Joint Res. 2014; 3(6):175-82. PMC: 4054013. DOI: 10.1302/2046-3758.36.2000239. View

13.

Browne J, Novicoff W, DApuzzo M . Medicaid payer status is associated with in-hospital morbidity and resource utilization following primary total joint arthroplasty. J Bone Joint Surg Am. 2014; 96(21):e180. DOI: 10.2106/JBJS.N.00133. View

14.

Pugely A, Martin C, Gao Y, Schweizer M, Callaghan J . The Incidence of and Risk Factors for 30-Day Surgical Site Infections Following Primary and Revision Total Joint Arthroplasty. J Arthroplasty. 2015; 30(9 Suppl):47-50. DOI: 10.1016/j.arth.2015.01.063. View

15.

Triantafyllopoulos G, Stundner O, Memtsoudis S, Poultsides L . Patient, Surgery, and Hospital Related Risk Factors for Surgical Site Infections following Total Hip Arthroplasty. ScientificWorldJournal. 2015; 2015:979560. PMC: 4446513. DOI: 10.1155/2015/979560. View

16.

Karlakki S, Hamad A, Whittall C, Graham N, Banerjee R, Kuiper J . Incisional negative pressure wound therapy dressings (iNPWTd) in routine primary hip and knee arthroplasties: A randomised controlled trial. Bone Joint Res. 2016; 5(8):328-37. PMC: 5013893. DOI: 10.1302/2046-3758.58.BJR-2016-0022.R1. View

17.

Allegranzi B, Bischoff P, de Jonge S, Kubilay N, Zayed B, Gomes S . New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect Dis. 2016; 16(12):e276-e287. DOI: 10.1016/S1473-3099(16)30398-X. View

18.

Allegranzi B, Zayed B, Bischoff P, Kubilay N, de Jonge S, de Vries F . New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect Dis. 2016; 16(12):e288-e303. DOI: 10.1016/S1473-3099(16)30402-9. View

19.

. Medicare Program; Advancing Care Coordination Through Episode Payment Models (EPMs); Cardiac Rehabilitation Incentive Payment Model; and Changes to the Comprehensive Care for Joint Replacement Model (CJR). Final rule. Fed Regist. 2017; 82(1):180-651. View

20.

Berrios-Torres S, Umscheid C, Bratzler D, Leas B, Stone E, Kelz R . Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg. 2017; 152(8):784-791. DOI: 10.1001/jamasurg.2017.0904. View